Abiopharma

🔍 Marshall Christopher P (Director)

Company: Nerdy Inc. (NRDY)

Report Date: 2026-04-30

Detailed Transactions and Holdings:

• Acquired 241,935 shares of Stock Option (Right to Buy) at $0.89 per share (Derivative)
  Date: 2026-04-30 | Code: A | Expires: 2036-04-30 | Exercise: 2027-04-30 | equity_swap_involved: 0 | shares_owned_after: 241,935.00 | transaction_form_type: 4 | Footnotes: F1, F3, F4
• Acquired 88,710 shares of Stock Option (Right to Buy) at $0.89 per share (Derivative)
  Date: 2026-04-30 | Code: A | Expires: 2036-04-30 | Exercise: 2027-04-30 | equity_swap_involved: 0 | shares_owned_after: 330,645.00 | transaction_form_type: 4 | Footnotes: F2, F3, F4

Footnotes:

• F1: The number of options issued reflects the value of the Reporting Person's annual equity award for service on the Nerdy Inc. Board of Directors.
• F2: The number of options issued reflects the value of the Reporting Person's annual cash retainer and additional annual retainer for committee memberships for the Nerdy Inc. Board of Directors. The Reporting Person has elected to have all or a portion of his additional annual cash retainer and annual retainer for committee memberships paid in the form of equity in lieu of cash compensation.
• F3: The stock options fully vest and become exercisable on the earlier of (i) the one year anniversary of the grant date (4/30/27), or (ii) the next annual meeting of Nerdy Inc. stockholders.
• F4: Mr. Marshall has sole voting and dispositive power over the options he holds directly. However, TCV VIII Management, L.L.C. has the right to 100% of the pecuniary interests in such options. Mr. Marshall is a member of TCV VIII Management, L.L.C. Mr. Marshall disclaims beneficial ownership of such options and the shares to be received upon the exercise of such options except to the extent of his pecuniary interest therein.